The molecular basis of the folate-sensitive fragile site FRA11A at 11q13

Cytogenetic and Genome Research

Volumn 119, Issue 1-2, 2007, Pages 9-14

  Debacker, K ^a   Winnepenninckx, B ^a   Longman, C ^b   Colgan, J ^b   Tolmie, J ^b   Murray, R ^c   Van Luijk, R ^a   Scheers, S ^a   FitzPatrick, D ^c   Kooy, F ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c Molecular Medicine Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FOLIC ACID; GENOMIC DNA;

ADOLESCENT; ARTICLE; C11ORF80 GENE; CASE REPORT; CHROMOSOME 11Q; CPG ISLAND; CYTOGENETICS; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DNA METHYLATION; FLUORESCENCE IN SITU HYBRIDIZATION; FRAGILE X SYNDROME; GENE; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; MALE; MENTAL DEFICIENCY; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

CHROMOSOME FRAGILE SITES; CHROMOSOMES, HUMAN, PAIR 11; COMPUTATIONAL BIOLOGY; FEMALE; FOLIC ACID; GENE EXPRESSION REGULATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PEDIGREE; PHENOTYPE;

EID: 37549072670     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109612     Document Type: Article

References (21)

1. Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, et al: Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 62:232-244 (1998).
2. Guichaoua M, Matteï MG, Matteï JF, Giraud F: Aspects genetiques des sites fragiles autosomiques. Apropos de 40 cas. J Genet Hum 30:183-197 (1982).
3. Iliopoulos D, Guler G, Han SY, Druck T, Ottey M, et al: Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett 232:27-36 (2006).
4. Jones C, Penny L, Mattina T, Yu S, Baker E, et al: Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 376:145-149 (1995).
5. Knight SJL, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, et al: Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74:127-134 (1993).
6. Kooy RF, Oostra BA, Willems PJ: The fragile X syndrome and other fragile site disorders. Results Probl Cell Differ 21:1-46 (1998).
7. Nancarrow JK, Kremer E, Holman K, Eyre H, Doggett NA, et al: Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science 264:1938-1941 (1994).
8. Ormandy CJ, Musgrove EA, Hui R, Daly RJ, Sutherland RL: Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 78:323-335 (2003).
9. Parrish JE, Oostra BA, Verkerk AJMH, Richards CS, Reynolds J, et al: Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet 8:229-235 (1994).
10. Sarafidou T, Kahl C, Martinez-Garay I, Mangelsdorf M, Gesk S, et al: Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1 , encoding a nuclear protein. Genomics 84:69-81 (2004).
11. Sessarego M, Ajmar F, Ravazzolo R, Bianchi Scarra GL, Garre C, Boccaccio P: Coincidence between fragile site expression and interstitial deletion of chromosome 11 in a case of myelofibrosis. Hum Genet 63:299-301 (1983).
12. Smeets DFCM, Scheres JMJC, Hustinx TWJ: Heritable fragility at 11q13 and 12q13. Clin Genet 28:145-150 (1985).
13. Sutherland GR: Heritable fragile sites on human chromosomes II. Distribution, phenotypic effects and cytogenetics. Am J Hum Genet 31:136-148 (1979).
14. Sutherland GR: Heritable fragile sites on human chromosomes. VIII. Preliminary population cytogenetic data on the folic-acid-sensitive fragile sites. Am J Hum Genet 34:452-458 (1982).
15. Sutherland GR, Baker E: Characterisation of a new rare fragile site easily confused with the fragile X. Hum Mol Genet 1:111-113 (1992).
16. Sutherland GR, Hecht F: Fragile sites on human chromosomes (Oxford University Press, New York 1985).
17. Takahashi E, Hori T, Murata M: Population cytogenetics of rare fragile sites in Japan. Hum Genet 78:121-126 (1988).
18. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DPA, et al: Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914 (1991).
19. Warner JP, Barron LH, Goudie D, Kelly K, Dow D, et al: A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 33:1022-1026 (1996).
20. Winnepenninckx B, Debacker K, Ramsay J, Smeets D, Smits A, et al: CGG repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1. Am J Hum Genet 80:221-231 (2007).
21. Zainabadi K, Benyamini P, Chakrabarti R, Veena MS, Chandrasekharappa SC, et al: A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13. Genomics 85:704-714 (2005).